Year of Award:
Molecular & Cellular Analysis Technologies
HIRSCHOWITZ, EDWARD A
Other PI or Project Leader:
20/20 GENESYSTEMS, INC.
Tumor markers, measured in peripheral blood, could assist in diagnosis and management of non-small cell lung cancer (NSCLC) and potentially improve historically dismal outcomes. Circulating antibodies, generated to a wide range of tumor-associated protein